Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
basket, Biopharma, California, CCPA, clonic, compelling, consummated, consummating, context, controversial, DBP, destroy, discontinued, email, endeavor, excessive, FOS, Kingdom, military, monotherapy, Morgan, MPC, Neurona, nil, notification, OLE, operationalize, overallotment, phenobarbital, PMPRB, pregabalin, presidential, quickly, reconsider, resurgence, Russia, Similarly, timeline, tonic, UK, Ukraine, Union, vigabatrin, weekly, whichever, Zhimeng
Removed:
accumulator, assistance, fiscal, manager, pharmacy, Relief, Supplemental
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view